Psoriasis and Climate Therapy- Effect of Motivational Follow- up Calls on Clinical and Health Economic Parameters
The aim of this study is to evaluate clinical and health economic parameters in relation to individual motivational counseling by phone.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Psoriasis and Climate Therapy- Effect of Motivational Follow- up Calls on Clinical and Health Economic Parameters|
- SAPASI (+ PASI at T1 and T2) [ Time Frame: Change in SAPASI from baseline, to 3 weeks, 6 weeks and 12 weeks ] [ Designated as safety issue: No ]The self-administered psoriasis area and severity index (SAPASI) is a structured instrument for measuring the severity of psoriasis.
- HeiQ [ Time Frame: change from baseline to 3 months, 6 months ] [ Designated as safety issue: No ]The heiQ™ is an Australian-developed health education impact evaluation system. It consists of a set of eight scales. Each scale is an independent questionnaire and together they provide a comprehensive profile of the intended outcomes of health education / self-management programs.
- 15D [ Time Frame: Change in 15D from baseline to 6 weeks and 12 weeks ] [ Designated as safety issue: No ]The 15D is a generic, comprehensive (15-dimensional), self-administered instrument for measuring HRQoL among adults (age 16+ years).
- Questionnaire about lifestyle [ Time Frame: Change in lifestyle parametres from baseline to 6 weeks and 12 weeks ] [ Designated as safety issue: No ]Questions about exercise, diet, stress, lifestyle change
- BIPQ-2 [ Time Frame: Change from baseline to 3 and 6 months ] [ Designated as safety issue: No ]short questionnaire about illness perception
- Psoriasis Knowledge questionnaire [ Time Frame: change in knowledge from baseline to 3 weeks, 3 months and 6 monthts ] [ Designated as safety issue: No ]40 questions about psoriasis and psoriasis treatment
- Willingness to change to manage psoriasis [ Time Frame: change from baseline to 3 months and 6 months ] [ Designated as safety issue: No ]8 questions about plans for change or conducted change managing psoriasis symptoms
|Study Start Date:||September 2011|
|Estimated Study Completion Date:||February 2015|
|Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|
No Intervention: usual care
Behavioral: Motivational interviewing
Motivational interviewing technique will be used to improve patient adherence to multiple health behaviour changes and support patients with psoriasis to self- manage effectively. The intervention will discuss on four main topics: diet, physical activity, stress management and psoriasis treatment.
Motivational interviewing is a patient centered directive counselling technique that focuses on assisting patients to identify their problems and involves exploring ambivalence in an empathic manner. A key goal in motivational interviewing is to increase the importance of change from the client`s perspective. This is accomplished by using specific types of open ended questions, selective reflections and reflective listening.
A chronic condition such as psoriasis requires a high level of self- management and requires for many patients behaviour change to improve health outcome. Changing behaviour is a challenge that requires a commitment by the patient to implement successfully. Motivational interviewing is a patient centered directive counseling technique that focuses on assisting patients to identify their problems and involves exploring ambivalence in an empathic manner. It is a well-known method of counseling, and is considered to be a useful intervention strategy in the treatment of lifestyle problems.
This study is a randomized controlled trial using telephone motivational interviewing. The counseling intervention comprises 6 telephone calls during a 12 week period, after attending 3 weeks of supervised climate therapy on the Canary Islands
Please refer to this study by its ClinicalTrials.gov identifier: NCT01352780
|Oslo University hospital, Department for clima therapy|
|Oslo, Norway, 0027|
|University of Oslo, Departement of health and society|
|Study Chair:||Astrid K. Wahl, PhD||University of Oslo, Departement of Health and Society,Department of Health Sciences|